Literature DB >> 21799203

Oligohydramnios associated with administration of weekly paclitaxel for triple-negative breast cancer during pregnancy.

M P Shieh1, R S Mehta2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21799203      PMCID： PMC3202168          DOI： 10.1093/annonc/mdr339

Source DB:  PubMed          Journal:  Ann Oncol        ISSN： 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  4 in total

1.  Anhydramnios associated with administration of trastuzumab and paclitaxel for metastatic breast cancer during pregnancy.

Authors:  Arnim A Bader; Dietmar Schlembach; Karl F Tamussino; Gunda Pristauz; Edgar Petru
Journal:  Lancet Oncol       Date:  2007-01       Impact factor: 41.316

2.  Dose-dense and/or metronomic schedules of specific chemotherapies consolidate the chemosensitivity of triple-negative breast cancer: a step toward reversing triple-negative paradox.

Authors:  Rita S Mehta
Journal:  J Clin Oncol       Date:  2008-07-01       Impact factor: 44.544

Review 3.  Taxanes for breast cancer during pregnancy: a systematic review.

Authors:  O Mir; P Berveiller; F Goffinet; J-M Treluyer; R Serreau; F Goldwasser; R Rouzier
Journal:  Ann Oncol       Date:  2009-11-03       Impact factor: 32.976

4.  Weekly paclitaxel in the adjuvant treatment of breast cancer.

Authors:  Joseph A Sparano; Molin Wang; Silvana Martino; Vicky Jones; Edith A Perez; Tom Saphner; Antonio C Wolff; George W Sledge; William C Wood; Nancy E Davidson
Journal:  N Engl J Med       Date:  2008-04-17       Impact factor: 91.245
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.